New device for peripheral nerve stim cuts chronic low back pain

March 20, 2017

(HealthDay)—A novel method of short-term percutaneous peripheral nerve stimulation (PNS) is useful for producing pain relief and reducing medication use among patients with chronic low back pain (LBP), according to a case report published online March 14 in Pain Practice.

Leonardo Kapural, M.D., Ph.D., from the Center for Clinical Research and Carolina's Pain Institute in Winston Salem, N.C., and colleagues describe the use of PNS in two subjects with chronic LBP. Stimulation was discontinued at the end of the one-month therapy and the leads were withdrawn.

The authors note that PNS produced clinically significant improvements in and functional outcomes (62 percent average reduction in Brief Pain Inventory Question #5, average pain; 73 percent reduction in disability, Oswestry Disability Index; 83 percent reduction in pain interference, Brief Pain Inventory). Non-opioid analgesic use was reduced by 83 percent on average, and the subject taking opioids ceased opioid use. Minor skin irritation caused by a topical dressing was the only adverse event. For at least four months after the start of therapy, clinically significant improvements were sustained (79 percent average reduction in pain; both reported minimal disability; and 100 and 74 percent reductions in opioids and non-opioids, respectively).

"This therapy has the potential to shift the paradigm in the management of , offering a minimally invasive treatment with the potential to bring the benefits of an effective neuromodulation therapy to patients earlier in the treatment continuum," the authors write.

Several authors disclosed financial ties to SPR Therapeutics, which funded the study. Several authors are listed as inventors on issued or pending patents.

Explore further: High-frequency spinal cord stimulation provides better results in chronic back and leg pain

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

High-frequency spinal cord stimulation provides better results in chronic back and leg pain

October 28, 2016
For patients with severe, chronic back and leg pain, a new high-frequency spinal cord stimulation (SCS) technique provides superior clinical outcomes, compared to conventional low-frequency SCS, reports a clinical trial in ...

Optimized treatment relieves pain in chronic pancreatitis

January 10, 2017
(HealthDay)—For most patients with chronic pancreatitis (CP), optimized medical and interventional treatment is associated with significant pain relief, according to a study published online Jan. 4 in the Journal of Gastroenterology ...

Occipital nerve stimulation effective for chronic migraine

October 29, 2016
(HealthDay)—For patients with chronic migraine (CM), peripheral nerve stimulation of the occipital nerves reduces the number of headache days, according to a study published online Oct. 25 in Pain Practice.

New therapy delivers long-term relief for chronic back, leg pain, study finds

July 28, 2015
Chronic back and leg pain sufferers in search of better pain relief options may have a new choice. According to a study published in the Online First edition of Anesthesiology, the official medical journal of the American ...

Basivertebral nerve ablation beneficial for chronic back pain

January 23, 2017
(HealthDay)—For patients with chronic lumbar back pain, ablation of the basivertebral nerve (BVN) improves self-reported outcome at three months and through one year, according to a study published in the February issue ...

Patient perception of provider concern impacts satisfaction

January 17, 2017
(HealthDay)—For patients with chronic pain receiving opioids, provider satisfaction is not associated with functional outcomes; however, patient perception of provider concern impacts perceived satisfaction, according to ...

Recommended for you

Largest oral HPV study in England shows infection rates lower than expected

August 20, 2018
Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.